14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 CADL stock ended at $10.83. This is 12.93% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 14.68% from a day low at $9.44 to a day high of $10.83.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Candel Therapeutics, Inc. prices

Date Open High Low Close Volume
May 08, 2024 $9.71 $10.83 $9.44 $10.83 1 134 345
May 07, 2024 $9.00 $9.63 $8.66 $9.59 761 386
May 06, 2024 $9.33 $10.86 $8.43 $8.85 1 875 559
May 03, 2024 $8.34 $9.39 $8.34 $9.02 999 743
May 02, 2024 $7.64 $8.78 $7.44 $8.43 1 249 520
May 01, 2024 $7.03 $7.98 $6.94 $7.98 1 086 967
Apr 30, 2024 $6.50 $7.30 $6.25 $7.05 1 111 385
Apr 29, 2024 $6.43 $6.60 $6.19 $6.41 363 479
Apr 26, 2024 $6.51 $6.60 $6.02 $6.39 386 083
Apr 25, 2024 $5.90 $6.81 $5.74 $6.43 739 737
Apr 24, 2024 $6.04 $6.33 $5.71 $6.05 663 877
Apr 23, 2024 $5.47 $5.98 $5.46 $5.91 447 573
Apr 22, 2024 $5.12 $5.68 $5.10 $5.54 575 876
Apr 19, 2024 $5.44 $5.55 $5.05 $5.17 515 312
Apr 18, 2024 $5.34 $5.99 $5.22 $5.46 737 960
Apr 17, 2024 $5.83 $5.95 $5.32 $5.44 829 509
Apr 16, 2024 $5.68 $6.34 $5.63 $5.89 1 067 120
Apr 15, 2024 $6.50 $6.60 $5.74 $5.82 2 166 875
Apr 12, 2024 $6.85 $7.50 $6.57 $6.66 6 700 424
Apr 11, 2024 $6.40 $7.92 $5.84 $7.28 63 606 644
Apr 10, 2024 $5.00 $5.53 $4.75 $5.10 2 726 298
Apr 09, 2024 $6.25 $6.52 $4.88 $5.09 3 703 942
Apr 08, 2024 $6.00 $7.84 $5.97 $6.43 15 429 886
Apr 05, 2024 $7.00 $11.40 $5.58 $6.64 83 255 459
Apr 04, 2024 $2.03 $7.65 $2.00 $6.40 131 534 489
Click to get the best stock tips daily for free!

About Candel Therapeutics, Inc.

Candel Therapeutics. Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi... CADL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT